Hard to back when the share price is less than the offer. Some of us who hold here are down 80% since the consolidation.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025